Table of Content

1 Study Coverage
1.1 Chronic Metabolic Disease Drug Product Introduction
1.2 Global Chronic Metabolic Disease Drug Outlook 2018 VS 2024 VS 2034
1.2.1 Global Chronic Metabolic Disease Drug Sales in US$ Million for the Year 2018-2034
1.2.2 Global Chronic Metabolic Disease Drug Sales in Volume for the Year 2018-2034
1.3 India Chronic Metabolic Disease Drug Outlook 2018 VS 2024 VS 2034
1.3.1 India Chronic Metabolic Disease Drug Sales in US$ Million for the Year 2018-2034
1.3.2 India Chronic Metabolic Disease Drug Sales in Volume for the Year 2018-2034
1.4 Chronic Metabolic Disease Drug Market Size, India VS Global, 2018 VS 2024 VS 2034
1.4.1 The Market Share of India Chronic Metabolic Disease Drug in Global, 2018 VS 2024 VS 2034
1.4.2 The Growth Rate of Chronic Metabolic Disease Drug Market Size, India VS Global, 2018 VS 2024 VS 2034
1.5 Chronic Metabolic Disease Drug Market Dynamics
1.5.1 Chronic Metabolic Disease Drug Industry Trends
1.5.2 Chronic Metabolic Disease Drug Market Drivers
1.5.3 Chronic Metabolic Disease Drug Market Challenges
1.5.4 Chronic Metabolic Disease Drug Market Restraints
1.6 Study Objectives
1.7 Years Considered
1.8 Years Considered
2 Chronic Metabolic Disease Drug by Type
2.1 Chronic Metabolic Disease Drug Market Segment by Type
2.1.1 Hypertension Drug
2.1.2 Hyperlipidemia Drug
2.1.3 High Blood Sugar Drug
2.1.4 High Uric Acid Drug
2.2 Global Chronic Metabolic Disease Drug Market Size by Type
2.2.1 Global Chronic Metabolic Disease Drug Sales in Value, by Type (2018, 2024 & 2034)
2.2.2 Global Chronic Metabolic Disease Drug Sales in Volume, by Type (2018, 2024 & 2034)
2.2.3 Global Chronic Metabolic Disease Drug Average Selling Price (ASP) by Type (2018, 2024 & 2034)
2.3 India Chronic Metabolic Disease Drug Market Size by Type
2.3.1 India Chronic Metabolic Disease Drug Sales in Value, by Type (2018, 2024 & 2034)
2.3.2 India Chronic Metabolic Disease Drug Sales in Volume, by Type (2018, 2024 & 2034)
2.3.3 India Chronic Metabolic Disease Drug Average Selling Price (ASP) by Type (2018, 2024 & 2034)
3 Chronic Metabolic Disease Drug by Application
3.1 Chronic Metabolic Disease Drug Market Segment by Application
3.1.1 Hospital
3.1.2 Clinic
3.1.3 Others
3.2 Global Chronic Metabolic Disease Drug Market Size by Application
3.2.1 Global Chronic Metabolic Disease Drug Sales in Value, by Application (2018, 2024 & 2034)
3.2.2 Global Chronic Metabolic Disease Drug Sales in Volume, by Application (2018, 2024 & 2034)
3.3.3 Global Chronic Metabolic Disease Drug Average Selling Price (ASP) by Application (2018, 2024 & 2034)
3.3 India Chronic Metabolic Disease Drug Market Size by Application
3.3.1 India Chronic Metabolic Disease Drug Sales in Value, by Application (2018, 2024 & 2034)
3.3.2 India Chronic Metabolic Disease Drug Sales in Volume, by Application (2018, 2024 & 2034)
3.3.3 India Chronic Metabolic Disease Drug Average Selling Price (ASP) by Application (2018, 2024 & 2034)
4 Global Chronic Metabolic Disease Drug Competitor Landscape by Company
4.1 Global Chronic Metabolic Disease Drug Market Size by Company
4.1.1 Global Key Manufacturers of Chronic Metabolic Disease Drug, Ranked by Revenue (2024)
4.1.2 Global Chronic Metabolic Disease Drug Revenue by Manufacturer (2018-2023)
4.1.3 Global Chronic Metabolic Disease Drug Sales by Manufacturer (2018-2023)
4.1.4 Global Chronic Metabolic Disease Drug Price by Manufacturer (2018-2023)
4.2 Global Chronic Metabolic Disease Drug Concentration Ratio (CR)
4.2.1 Chronic Metabolic Disease Drug Market Concentration Ratio (CR)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Chronic Metabolic Disease Drug in 2024
4.2.3 Global Chronic Metabolic Disease Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Manufacturers of Chronic Metabolic Disease Drug, Manufacturing Base Distribution and Headquarters
4.4 Global Key Manufacturers of Chronic Metabolic Disease Drug, Product Offered and Application
4.5 Global Key Manufacturers of Chronic Metabolic Disease Drug, Date of Enter into This Industry
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4.7 India Chronic Metabolic Disease Drug Market Size by Company
4.7.1 Key Players of Chronic Metabolic Disease Drug in India, Ranked by Revenue (2024)
4.7.2 India Chronic Metabolic Disease Drug Revenue by Players (2018-2023)
4.7.3 India Chronic Metabolic Disease Drug Sales by Players (2018-2023)
5 Global Chronic Metabolic Disease Drug Market Size by Region
5.1 Global Chronic Metabolic Disease Drug Market Size by Region: 2018 VS 2024 VS 2034
5.2 Global Chronic Metabolic Disease Drug Market Size in Volume by Region (2018-2034)
5.2.1 Global Chronic Metabolic Disease Drug Sales in Volume by Region: 2018-2023
5.2.2 Global Chronic Metabolic Disease Drug Sales in Volume Forecast by Region (2024-2034)
5.3 Global Chronic Metabolic Disease Drug Market Size in Value by Region (2018-2034)
5.3.1 Global Chronic Metabolic Disease Drug Sales in Value by Region: 2018-2023
5.3.2 Global Chronic Metabolic Disease Drug Sales in Value by Region: 2024-2034
6 Americas
6.1 Americas Chronic Metabolic Disease Drug Market Size YoY Growth 2018-2034
6.2 Americas Chronic Metabolic Disease Drug Sales in Volume, by Type (2018, 2024 & 2034)
6.3 Americas Chronic Metabolic Disease Drug Sales in Volume, by Application (2018, 2024 & 2034)
6.4 Americas Chronic Metabolic Disease Drug Market Facts & Figures by Country (2018, 2024 & 2034)
6.4.1 Americas Chronic Metabolic Disease Drug Sales in Value by Country (2018, 2024 & 2034)
6.4.2 Americas Chronic Metabolic Disease Drug Sales in Volume by Country (2018, 2024 & 2034)
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico
6.4.6 Brazil
7 EMEA
7.1 EMEA Chronic Metabolic Disease Drug Market Size YoY Growth 2018-2034
7.2 EMEA Chronic Metabolic Disease Drug Sales in Volume, by Type (2018, 2024 & 2034)
7.3 EMEA Chronic Metabolic Disease Drug Sales in Volume, by Application (2018, 2024 & 2034)
7.4 EMEA Chronic Metabolic Disease Drug Market Facts & Figures by Country (2018, 2024 & 2034)
7.4.1 EMEA Chronic Metabolic Disease Drug Sales in Value by Country (2018, 2024 & 2034)
7.4.2 EMEA Chronic Metabolic Disease Drug Sales in Volume by Country (2018, 2024 & 2034)
7.4.3 Europe
7.4.4 Middle East
7.4.5 Africa
8 China
8.1 China Chronic Metabolic Disease Drug Market Size YoY Growth 2018-2034
8.2 China Chronic Metabolic Disease Drug Sales in Volume, by Type (2018, 2024 & 2034)
8.3 China Chronic Metabolic Disease Drug Sales in Volume, by Application (2018, 2024 & 2034)
9 APAC
9.1 APAC Chronic Metabolic Disease Drug Market Size YoY Growth 2018-2034
9.2 APAC Chronic Metabolic Disease Drug Sales in Volume, by Type (2018, 2024 & 2034)
9.3 APAC Chronic Metabolic Disease Drug Sales in Volume, by Application (2018, 2024 & 2034)
9.4 APAC Chronic Metabolic Disease Drug Market Facts & Figures by Region (2018, 2024 & 2034)
9.4.1 APAC Chronic Metabolic Disease Drug Sales in Value by Region (2018, 2024 & 2034)
9.4.2 APAC Chronic Metabolic Disease Drug Sales in Volume by Region (2018, 2024 & 2034)
9.4.3 Japan
9.4.4 South Korea
9.4.5 China Taiwan
9.4.6 Southeast Asia
9.4.7 India
10 Company Profiles
10.1 Novartis
10.1.1 Novartis Company Information
10.1.2 Novartis Description and Business Overview
10.1.3 Novartis Chronic Metabolic Disease Drug Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Novartis Chronic Metabolic Disease Drug Products Offered
10.1.5 Novartis Recent Development
10.2 Daiichi Sankyo
10.2.1 Daiichi Sankyo Company Information
10.2.2 Daiichi Sankyo Description and Business Overview
10.2.3 Daiichi Sankyo Chronic Metabolic Disease Drug Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Daiichi Sankyo Chronic Metabolic Disease Drug Products Offered
10.2.5 Daiichi Sankyo Recent Development
10.3 Actelion Pharmaceuticals
10.3.1 Actelion Pharmaceuticals Company Information
10.3.2 Actelion Pharmaceuticals Description and Business Overview
10.3.3 Actelion Pharmaceuticals Chronic Metabolic Disease Drug Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Actelion Pharmaceuticals Chronic Metabolic Disease Drug Products Offered
10.3.5 Actelion Pharmaceuticals Recent Development
10.4 Boehringer Ingelheim
10.4.1 Boehringer Ingelheim Company Information
10.4.2 Boehringer Ingelheim Description and Business Overview
10.4.3 Boehringer Ingelheim Chronic Metabolic Disease Drug Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Boehringer Ingelheim Chronic Metabolic Disease Drug Products Offered
10.4.5 Boehringer Ingelheim Recent Development
10.5 Eli Lilly
10.5.1 Eli Lilly Company Information
10.5.2 Eli Lilly Description and Business Overview
10.5.3 Eli Lilly Chronic Metabolic Disease Drug Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Eli Lilly Chronic Metabolic Disease Drug Products Offered
10.5.5 Eli Lilly Recent Development
10.6 Fresenius Kabi
10.6.1 Fresenius Kabi Company Information
10.6.2 Fresenius Kabi Description and Business Overview
10.6.3 Fresenius Kabi Chronic Metabolic Disease Drug Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Fresenius Kabi Chronic Metabolic Disease Drug Products Offered
10.6.5 Fresenius Kabi Recent Development
10.7 Torrent Labs
10.7.1 Torrent Labs Company Information
10.7.2 Torrent Labs Description and Business Overview
10.7.3 Torrent Labs Chronic Metabolic Disease Drug Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Torrent Labs Chronic Metabolic Disease Drug Products Offered
10.7.5 Torrent Labs Recent Development
10.8 Pfizer
10.8.1 Pfizer Company Information
10.8.2 Pfizer Description and Business Overview
10.8.3 Pfizer Chronic Metabolic Disease Drug Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Pfizer Chronic Metabolic Disease Drug Products Offered
10.8.5 Pfizer Recent Development
10.9 Novo Nordisk
10.9.1 Novo Nordisk Company Information
10.9.2 Novo Nordisk Description and Business Overview
10.9.3 Novo Nordisk Chronic Metabolic Disease Drug Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Novo Nordisk Chronic Metabolic Disease Drug Products Offered
10.9.5 Novo Nordisk Recent Development
10.10 AstraZeneca plc
10.10.1 AstraZeneca plc Company Information
10.10.2 AstraZeneca plc Description and Business Overview
10.10.3 AstraZeneca plc Chronic Metabolic Disease Drug Sales, Revenue and Gross Margin (2018-2023)
10.10.4 AstraZeneca plc Chronic Metabolic Disease Drug Products Offered
10.10.5 AstraZeneca plc Recent Development
10.11 Regeneron Pharmaceuticals
10.11.1 Regeneron Pharmaceuticals Company Information
10.11.2 Regeneron Pharmaceuticals Description and Business Overview
10.11.3 Regeneron Pharmaceuticals Chronic Metabolic Disease Drug Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Regeneron Pharmaceuticals Chronic Metabolic Disease Drug Products Offered
10.11.5 Regeneron Pharmaceuticals Recent Development
10.12 GlaxoSmithKline plc
10.12.1 GlaxoSmithKline plc Company Information
10.12.2 GlaxoSmithKline plc Description and Business Overview
10.12.3 GlaxoSmithKline plc Chronic Metabolic Disease Drug Sales, Revenue and Gross Margin (2018-2023)
10.12.4 GlaxoSmithKline plc Chronic Metabolic Disease Drug Products Offered
10.12.5 GlaxoSmithKline plc Recent Development
10.13 Merck & Co. Inc
10.13.1 Merck & Co. Inc Company Information
10.13.2 Merck & Co. Inc Description and Business Overview
10.13.3 Merck & Co. Inc Chronic Metabolic Disease Drug Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Merck & Co. Inc Chronic Metabolic Disease Drug Products Offered
10.13.5 Merck & Co. Inc Recent Development
11 Industry Chain and Sales Channels Analysis
11.1 Chronic Metabolic Disease Drug Industry Chain Analysis
11.2 Chronic Metabolic Disease Drug Key Raw Materials
11.2.1 Key Raw Materials
11.2.2 Raw Materials Key Suppliers
11.3 Chronic Metabolic Disease Drug Production Mode & Process
11.4 Chronic Metabolic Disease Drug Sales and Marketing
11.4.1 Chronic Metabolic Disease Drug Sales Channels
11.4.2 Chronic Metabolic Disease Drug Distributors
11.5 Chronic Metabolic Disease Drug Customers
12 Research Findings and Conclusion
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Figure

List of Tables
Table 1. Chronic Metabolic Disease Drug CAGR in Value, India VS Global, 2018 VS 2024 VS 2034
Table 2. Chronic Metabolic Disease Drug Market Trends
Table 3. Chronic Metabolic Disease Drug Market Drivers
Table 4. Chronic Metabolic Disease Drug Market Challenges
Table 5. Chronic Metabolic Disease Drug Market Restraints
Table 6. Global Chronic Metabolic Disease Drug Sales Growth Rate (CAGR) by Type: 2018 VS 2024 VS 2034 (US$ Million)
Table 7. India Chronic Metabolic Disease Drug Sales Growth Rate (CAGR) by Type: 2018 VS 2024 VS 2034 (US$ Million)
Table 8. Global Chronic Metabolic Disease Drug Sales Growth Rate (CAGR) by Application: 2018 VS 2024 VS 2034 (US$ Million)
Table 9. India Chronic Metabolic Disease Drug Sales Growth Rate (CAGR) by Application: 2018 VS 2024 VS 2034 (US$ Million)
Table 10. Global Key Manufacturers of Chronic Metabolic Disease Drug, Ranked by Revenue (2024) & (US$ Million)
Table 11. Global Chronic Metabolic Disease Drug Revenue by Manufacturer, (US$ Million), 2018-2023
Table 12. Global Chronic Metabolic Disease Drug Revenue Share by Manufacturer, 2018-2023
Table 13. Global Chronic Metabolic Disease Drug Sales by Manufacturer, (K Units), 2018-2023
Table 14. Global Chronic Metabolic Disease Drug Sales Share by Manufacturer, 2018-2023
Table 15. Global Chronic Metabolic Disease Drug Price by Manufacturer (2018-2023) & (US$/Unit)
Table 16. Global Chronic Metabolic Disease Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Chronic Metabolic Disease Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Metabolic Disease Drug as of 2024)
Table 18. Global Key Manufacturers of Chronic Metabolic Disease Drug, Manufacturing Base Distribution and Headquarters
Table 19. Global Key Manufacturers of Chronic Metabolic Disease Drug, Product Offered and Application
Table 20. Global Key Manufacturers of Chronic Metabolic Disease Drug, Date of Enter into This Industry
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Key Players of Chronic Metabolic Disease Drug in India, Ranked by Revenue (2024) & (US$ million)
Table 23. India Chronic Metabolic Disease Drug Revenue by Players, (US$ Million), (2018-2023)
Table 24. India Chronic Metabolic Disease Drug Revenue Share by Players, (2018-2023)
Table 25. India Chronic Metabolic Disease Drug Sales by Players, (K Units), (2018-2023)
Table 26. India Chronic Metabolic Disease Drug Sales Share by Players, (2018-2023)
Table 27. Global Chronic Metabolic Disease Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2024 VS 2034
Table 28. Global Chronic Metabolic Disease Drug Sales in Volume by Region (2018-2023) & (K Units)
Table 29. Global Chronic Metabolic Disease Drug Sales in Volume Forecast by Region (2024-2034) & (K Units)
Table 30. Global Chronic Metabolic Disease Drug Sales in Value by Region (2018-2023) & (US$ Million)
Table 31. Global Chronic Metabolic Disease Drug Sales in Value Forecast by Region (2024-2034) & (US$ Million)
Table 32. Americas Chronic Metabolic Disease Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 33. Americas Chronic Metabolic Disease Drug Sales in Value by Country (2018-2023) & (US$ Million)
Table 34. Americas Chronic Metabolic Disease Drug Sales in Value by Country (2024-2034) & (US$ Million)
Table 35. Americas Chronic Metabolic Disease Drug Sales in Volume by Country (2018-2023) & (K Units)
Table 36. Americas Chronic Metabolic Disease Drug Sales in Volume by Country (2024-2034) & (K Units)
Table 37. EMEA Chronic Metabolic Disease Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 38. EMEA Chronic Metabolic Disease Drug Sales in Value by Country (2018-2023) & (US$ Million)
Table 39. EMEA Chronic Metabolic Disease Drug Sales in Value by Country (2024-2034) & (US$ Million)
Table 40. EMEA Chronic Metabolic Disease Drug Sales in Volume by Country (2018-2023) & (K Units)
Table 41. EMEA Chronic Metabolic Disease Drug Sales in Volume by Country (2024-2034) & (K Units)
Table 42. APAC Chronic Metabolic Disease Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 43. APAC Chronic Metabolic Disease Drug Sales in Value by Country (2018-2023) & (US$ Million)
Table 44. APAC Chronic Metabolic Disease Drug Sales in Value by Country (2024-2034) & (US$ Million)
Table 45. APAC Chronic Metabolic Disease Drug Sales in Volume by Country (2018-2023) & (K Units)
Table 46. APAC Chronic Metabolic Disease Drug Sales in Volume by Country (2024-2034) & (K Units)
Table 47. Novartis Company Information
Table 48. Novartis Description and Business Overview
Table 49. Novartis Chronic Metabolic Disease Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 50. Novartis Chronic Metabolic Disease Drug Product
Table 51. Novartis Recent Development
Table 52. Daiichi Sankyo Company Information
Table 53. Daiichi Sankyo Description and Business Overview
Table 54. Daiichi Sankyo Chronic Metabolic Disease Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 55. Daiichi Sankyo Chronic Metabolic Disease Drug Product
Table 56. Daiichi Sankyo Recent Development
Table 57. Actelion Pharmaceuticals Company Information
Table 58. Actelion Pharmaceuticals Description and Business Overview
Table 59. Actelion Pharmaceuticals Chronic Metabolic Disease Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 60. Actelion Pharmaceuticals Chronic Metabolic Disease Drug Product
Table 61. Actelion Pharmaceuticals Recent Development
Table 62. Boehringer Ingelheim Company Information
Table 63. Boehringer Ingelheim Description and Business Overview
Table 64. Boehringer Ingelheim Chronic Metabolic Disease Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 65. Boehringer Ingelheim Chronic Metabolic Disease Drug Product
Table 66. Boehringer Ingelheim Recent Development
Table 67. Eli Lilly Company Information
Table 68. Eli Lilly Description and Business Overview
Table 69. Eli Lilly Chronic Metabolic Disease Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 70. Eli Lilly Chronic Metabolic Disease Drug Product
Table 71. Eli Lilly Recent Development
Table 72. Fresenius Kabi Company Information
Table 73. Fresenius Kabi Description and Business Overview
Table 74. Fresenius Kabi Chronic Metabolic Disease Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 75. Fresenius Kabi Chronic Metabolic Disease Drug Product
Table 76. Fresenius Kabi Recent Development
Table 77. Torrent Labs Company Information
Table 78. Torrent Labs Description and Business Overview
Table 79. Torrent Labs Chronic Metabolic Disease Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 80. Torrent Labs Chronic Metabolic Disease Drug Product
Table 81. Torrent Labs Recent Development
Table 82. Pfizer Company Information
Table 83. Pfizer Description and Business Overview
Table 84. Pfizer Chronic Metabolic Disease Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 85. Pfizer Chronic Metabolic Disease Drug Product
Table 86. Pfizer Recent Development
Table 87. Novo Nordisk Company Information
Table 88. Novo Nordisk Description and Business Overview
Table 89. Novo Nordisk Chronic Metabolic Disease Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 90. Novo Nordisk Chronic Metabolic Disease Drug Product
Table 91. Novo Nordisk Recent Development
Table 92. AstraZeneca plc Company Information
Table 93. AstraZeneca plc Description and Business Overview
Table 94. AstraZeneca plc Chronic Metabolic Disease Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 95. AstraZeneca plc Chronic Metabolic Disease Drug Product
Table 96. AstraZeneca plc Recent Development
Table 97. Regeneron Pharmaceuticals Company Information
Table 98. Regeneron Pharmaceuticals Description and Business Overview
Table 99. Regeneron Pharmaceuticals Chronic Metabolic Disease Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 100. Regeneron Pharmaceuticals Chronic Metabolic Disease Drug Product
Table 101. Regeneron Pharmaceuticals Recent Development
Table 102. GlaxoSmithKline plc Company Information
Table 103. GlaxoSmithKline plc Description and Business Overview
Table 104. GlaxoSmithKline plc Chronic Metabolic Disease Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 105. GlaxoSmithKline plc Chronic Metabolic Disease Drug Product
Table 106. GlaxoSmithKline plc Recent Development
Table 107. Merck & Co. Inc Company Information
Table 108. Merck & Co. Inc Description and Business Overview
Table 109. Merck & Co. Inc Chronic Metabolic Disease Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 110. Merck & Co. Inc Chronic Metabolic Disease Drug Product
Table 111. Merck & Co. Inc Recent Development
Table 112. Key Raw Materials Lists
Table 113. Raw Materials Key Suppliers Lists
Table 114. Chronic Metabolic Disease Drug Customers List
Table 115. Chronic Metabolic Disease Drug Distributors List
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Chronic Metabolic Disease Drug Product Picture
Figure 2. Global Chronic Metabolic Disease Drug Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 3. Global Chronic Metabolic Disease Drug Market Size 2018-2034 (US$ Million)
Figure 4. Global Chronic Metabolic Disease Drug Sales 2018-2034 (K Units)
Figure 5. India Chronic Metabolic Disease Drug Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 6. India Chronic Metabolic Disease Drug Market Size 2018-2034 (US$ Million)
Figure 7. India Chronic Metabolic Disease Drug Sales 2018-2034 (K Units)
Figure 8. India Chronic Metabolic Disease Drug Market Share in Global, in Value (US$ Million) 2018-2034
Figure 9. India Chronic Metabolic Disease Drug Market Share in Global, in Volume (K Units) 2018-2034
Figure 10. Chronic Metabolic Disease Drug Report Years Considered
Figure 11. Product Picture of Hypertension Drug
Figure 12. Product Picture of Hyperlipidemia Drug
Figure 13. Product Picture of High Blood Sugar Drug
Figure 14. Product Picture of High Uric Acid Drug
Figure 15. Global Chronic Metabolic Disease Drug Market Share by Type in 2024 & 2034
Figure 16. Global Chronic Metabolic Disease Drug Sales in Value by Type (2018-2034) & (US$ Million)
Figure 17. Global Chronic Metabolic Disease Drug Sales Market Share in Value by Type (2018-2034)
Figure 18. Global Chronic Metabolic Disease Drug Sales by Type (2018-2034) & (K Units)
Figure 19. Global Chronic Metabolic Disease Drug Sales Market Share in Volume by Type (2018-2034)
Figure 20. Global Chronic Metabolic Disease Drug Price by Type (2018-2034) & (US$/Unit)
Figure 21. India Chronic Metabolic Disease Drug Market Share by Type in 2024 & 2034
Figure 22. India Chronic Metabolic Disease Drug Sales in Value by Type (2018-2034) & (US$ Million)
Figure 23. India Chronic Metabolic Disease Drug Sales Market Share in Value by Type (2018-2034)
Figure 24. India Chronic Metabolic Disease Drug Sales by Type (2018-2034) & (K Units)
Figure 25. India Chronic Metabolic Disease Drug Sales Market Share in Volume by Type (2018-2034)
Figure 26. India Chronic Metabolic Disease Drug Price by Type (2018-2034) & (US$/Unit)
Figure 27. Product Picture of Hospital
Figure 28. Product Picture of Clinic
Figure 29. Product Picture of Others
Figure 30. Global Chronic Metabolic Disease Drug Market Share by Application in 2024 & 2034
Figure 31. Global Chronic Metabolic Disease Drug Sales in Value by Application (2018-2034) & (US$ Million)
Figure 32. Global Chronic Metabolic Disease Drug Sales Market Share in Value by Application (2018-2034)
Figure 33. Global Chronic Metabolic Disease Drug Sales by Application (2018-2034) & (K Units)
Figure 34. Global Chronic Metabolic Disease Drug Sales Market Share in Volume by Application (2018-2034)
Figure 35. Global Chronic Metabolic Disease Drug Price by Application (2018-2034) & (US$/Unit)
Figure 36. India Chronic Metabolic Disease Drug Market Share by Application in 2024 & 2034
Figure 37. India Chronic Metabolic Disease Drug Sales in Value by Application (2018-2034) & (US$ Million)
Figure 38. India Chronic Metabolic Disease Drug Sales Market Share in Value by Application (2018-2034)
Figure 39. India Chronic Metabolic Disease Drug Sales by Application (2018-2034) & (K Units)
Figure 40. India Chronic Metabolic Disease Drug Sales Market Share in Volume by Application (2018-2034)
Figure 41. India Chronic Metabolic Disease Drug Price by Application (2018-2034) & (US$/Unit)
Figure 42. Americas Chronic Metabolic Disease Drug Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 43. Americas Chronic Metabolic Disease Drug Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 44. Americas Chronic Metabolic Disease Drug Sales by Type (2018-2034) & (K Units)
Figure 45. Americas Chronic Metabolic Disease Drug Sales Market Share in Volume by Type (2018-2034)
Figure 46. Americas Chronic Metabolic Disease Drug Sales by Application (2018-2034) & (K Units)
Figure 47. Americas Chronic Metabolic Disease Drug Sales Market Share in Volume by Application (2018-2034)
Figure 48. United States Chronic Metabolic Disease Drug Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 49. Canada Chronic Metabolic Disease Drug Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 50. Mexico Chronic Metabolic Disease Drug Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 51. Brazil Chronic Metabolic Disease Drug Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 52. EMEA Chronic Metabolic Disease Drug Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 53. EMEA Chronic Metabolic Disease Drug Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 54. EMEA Chronic Metabolic Disease Drug Sales by Type (2018-2034) & (K Units)
Figure 55. EMEA Chronic Metabolic Disease Drug Sales Market Share in Volume by Type (2018-2034)
Figure 56. EMEA Chronic Metabolic Disease Drug Sales by Application (2018-2034) & (K Units)
Figure 57. EMEA Chronic Metabolic Disease Drug Sales Market Share in Volume by Application (2018-2034)
Figure 58. Europe Chronic Metabolic Disease Drug Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 59. Middle East Chronic Metabolic Disease Drug Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 60. Africa Chronic Metabolic Disease Drug Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 61. China Chronic Metabolic Disease Drug Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 62. China Chronic Metabolic Disease Drug Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 63. China Chronic Metabolic Disease Drug Sales by Type (2018-2034) & (K Units)
Figure 64. China Chronic Metabolic Disease Drug Sales Market Share in Volume by Type (2018-2034)
Figure 65. China Chronic Metabolic Disease Drug Sales by Application (2018-2034) & (K Units)
Figure 66. China Chronic Metabolic Disease Drug Sales Market Share in Volume by Application (2018-2034)
Figure 67. APAC Chronic Metabolic Disease Drug Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 68. APAC Chronic Metabolic Disease Drug Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 69. APAC Chronic Metabolic Disease Drug Sales by Type (2018-2034) & (K Units)
Figure 70. APAC Chronic Metabolic Disease Drug Sales Market Share in Volume by Type (2018-2034)
Figure 71. APAC Chronic Metabolic Disease Drug Sales by Application (2018-2034) & (K Units)
Figure 72. APAC Chronic Metabolic Disease Drug Sales Market Share in Volume by Application (2018-2034)
Figure 73. Japan Chronic Metabolic Disease Drug Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 74. South Korea Chronic Metabolic Disease Drug Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 75. China Taiwan Chronic Metabolic Disease Drug Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 76. Southeast Asia Chronic Metabolic Disease Drug Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 77. India Chronic Metabolic Disease Drug Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 78. Chronic Metabolic Disease Drug Value Chain
Figure 79. Chronic Metabolic Disease Drug Production Process
Figure 80. Channels of Distribution
Figure 81. Distributors Profiles
Figure 82. Bottom-up and Top-down Approaches for This Report
Figure 83. Data Triangulation
Figure 84. Key Executives Interviewed